US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about XNAS:UNCY

Recent news which mentions XNAS:UNCY

Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Tickers UNCY
Tags XNAS:UNCY en/US Levi & Korsinsky, LLP
From TheNewswire.com - RSS (Media)
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Tickers UNCY
Tags Levi & Korsinsky, LLP XNAS:UNCY en/US
From TheNewswire.com - RSS (Media)
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to a Securities Class Action Lawsuit - Deadline is October 14, 2025
Tickers UNCY
Tags XNAS:UNCY Kaplan Fox en/US
From TheNewswire.com - RSS (Media)
Shareholders of Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Tickers UNCY
Tags en/US XNAS:UNCY Levi & Korsinsky, LLP
From TheNewswire.com - RSS (Media)
Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Tickers UNCY
Tags XNAS:UNCY Kaplan Fox en/US
From TheNewswire.com - RSS (Media)
Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
Tickers UNCY
Tags XNAS:UNCY en/US Kaplan Fox
From TheNewswire.com - RSS (Media)
Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Tickers UNCY
Tags en/US Kaplan Fox XNAS:UNCY
From TheNewswire.com - RSS (Media)
Kaplan Fox Announces an Investigation Into Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Tickers UNCY
Tags XNAS:UNCY Kaplan Fox en/US
From TheNewswire.com - RSS (Media)
The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
Tickers UNCY
Tags Unicycive Therapeutics, Inc/ XNAS:UNCY
From TheNewswire.com - RSS (Media)
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
Tickers UNCY
Tags Unicycive Therapeutics, Inc/ XNAS:UNCY
From TheNewswire.com - RSS (Media)
Unicycive: The Company Developing Key Kidney Therapies
Tickers UNCY
Tags Unicycive Therapeutics, Inc/ XNAS:UNCY
From TheNewswire.com - RSS (Media)
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
Tickers AKBA ARDX CARA UNCY
Tags XNAS:UNCY Unicycive Therapeautics, Inc/
From TheNewswire.com - RSS (Media)
Unicycive’s Doug Jermasek, EVP-Corporate Development Discusses the Importance of Medication Compliance and the Issues with Pill Burden
Tags Unicycive Therapeautics, Inc/ XNAS:UNCY
From TheNewswire.com - RSS (Media)
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
Tickers AKBA DVA UNCY
Tags Unicycive Therapeautics, Inc/ XNAS:UNCY
From TheNewswire.com - RSS (Media)
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
Tickers AKBA FMS LPCUF UNCY
Tags XNAS:UNCY Unicycive Therapeautics, Inc/
From TheNewswire.com - RSS (Media)